PT  - JOURNAL ARTICLE
AU  - Mohammadi, Abbas
AU  - Etemad, Behzad
AU  - Zhang, Xin
AU  - Li, Yijia
AU  - Bedwell, Gregory J.
AU  - Sharaf, Radwa
AU  - Kittilson, Autumn
AU  - Melberg, Meghan
AU  - Wong, Colline
AU  - Fajnzylber, Jesse
AU  - Worrall, Daniel P.
AU  - Rosenthal, Alex
AU  - Jordan, Hannah
AU  - Jilg, Nikolaus
AU  - Kaseke, Clarety
AU  - Giguel, Francoise
AU  - Lian, Xiaodong
AU  - Deo, Rinki
AU  - Gillespie, Elisabeth
AU  - Chishti, Rida
AU  - Abrha, Sara
AU  - Adams, Taylor
AU  - Siagian, Abigail
AU  - Anderson, Peter L.
AU  - Deeks, Steven G.
AU  - Lederman, Michael M.
AU  - Yawetz, Sigal
AU  - Kuritzkes, Daniel R.
AU  - Lichterfeld, Mathias D.
AU  - Tsibris, Athe
AU  - Carrington, Mary
AU  - Brumme, Zabrina L.
AU  - Castillo-Mancilla, Jose R.
AU  - Engelman, Alan N.
AU  - Gaiha, Gaurav D.
AU  - Li, Jonathan Z.
TI  - Viral and Host Mediators of Non-Suppressible HIV-1 Viremia
AID  - 10.1101/2023.03.30.23287124
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.30.23287124
4099  - http://medrxiv.org/content/early/2023/03/31/2023.03.30.23287124.short
4100  - http://medrxiv.org/content/early/2023/03/31/2023.03.30.23287124.full
AB  - Non-suppressible HIV-1 viremia (NSV) can occur in persons with HIV despite adherence to combination antiretroviral therapy (ART) and in the absence of significant drug resistance. Here, we show that plasma NSV sequences are comprised primarily of large clones without evidence of viral evolution over time. We defined proviruses that contribute to plasma viremia as “producer”, and those that did not as “non-producer”. Compared to ART-suppressed individuals, NSV participants had a significantly larger producer reservoir. Producer proviruses were enriched in chromosome 19 and in proximity to the activating H3K36me3 epigenetic mark. CD4+ cells from NSV participants demonstrated upregulation of anti-apoptotic genes and downregulation of pro-apoptotic and type I/II interferon-related pathways. Furthermore, NSV participants showed no elevation in HIV-specific CD8+ cell responses and producer proviruses were enriched for HLA escape mutations. We identified critical host and viral mediators of NSV that represent potential targets to disrupt HIV persistence and promote viral silencing.Competing Interest StatementJRCM has received funding from Gilead Sciences for investigator initiated research paid to his institution. PLA has received past consulting fees from Gilead, ViiV and Merck and research funding from Gilead paid to institution, unrelated to this work. JZL has consulted for Abbvie and received grant funding from Merck.Funding StatementThis work was supported in part by the Harvard University Center for AIDS Research (AI060354), NIH grants AI169768 (JZL), AI068634, AI068636 and AI106701. This project has been funded in part with federal funds from the Frederick National Laboratory for Cancer Research, under Contract No. 75N91019D00024. R37AI039394 (ANE), U54AI170791 (ANE).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional review board of Mass General Brigham gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors